CST3 and acute kidney injury: In the validation cohort, reclassification to a higher stage by cystatin C was an independent predictor of increased risk of death.<h4>Conclusion</h4>In critically ill patients, cystatin C-based staging identified more AKI than KDIGO criteria, and these patients had increased short- and long-term mortality.